Published in J Gen Intern Med on January 01, 2010
Defining core issues in utilizing information technology to improve access: evaluation and research agenda. J Gen Intern Med (2011) 0.87
Connecting research and patient care: lessons from the VA's Quality Enhancement Research Initiative. J Gen Intern Med (2010) 0.84
What can the VA teach us about implementing proven advances into routine clinical practice? J Gen Intern Med (2010) 0.75
Systematic review: impact of health information technology on quality, efficiency, and costs of medical care. Ann Intern Med (2006) 24.62
Electronic health records in ambulatory care--a national survey of physicians. N Engl J Med (2008) 17.18
Can electronic medical record systems transform health care? Potential health benefits, savings, and costs. Health Aff (Millwood) (2005) 9.63
AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res (2007) 5.60
Electronic health records: just around the corner? Or over the cliff? Ann Intern Med (2005) 4.74
Quality Enhancement Research Initiative (QUERI): A collaboration between research and clinical practice. Med Care (2000) 3.37
Exploring barriers and facilitators to the use of computerized clinical reminders. J Am Med Inform Assoc (2005) 2.82
Overview of the Veterans Health Administration (VHA) Quality Enhancement Research Initiative (QUERI). J Am Med Inform Assoc (2004) 2.78
Assessing the level of healthcare information technology adoption in the United States: a snapshot. BMC Med Inform Decis Mak (2006) 2.76
Depression decision support in primary care: a cluster randomized trial. Ann Intern Med (2006) 2.50
Implementation of evidence-based alcohol screening in the Veterans Health Administration. Am J Manag Care (2006) 1.83
Translating research into practice: organizational issues in implementing automated decision support for hypertension in three medical centers. J Am Med Inform Assoc (2004) 1.75
The cost of operating institutional review boards (IRBs). Acad Med (2003) 1.54
Advancing evidence-based care for diabetes: lessons from the Veterans Health Administration. Health Aff (Millwood) (2007) 1.53
Priorities and strategies for the implementation of integrated informatics and communications technology to improve evidence-based practice. J Gen Intern Med (2006) 1.49
Informatics resources to support health care quality improvement in the veterans health administration. J Am Med Inform Assoc (2004) 1.47
Adopting information technology to drive improvements in patient safety: lessons from the Agency for Healthcare Research and Quality health information technology grantees. Health Serv Res (2009) 1.43
Variations in evidence-based clinical practices in nine United States Veterans Administration opioid agonist therapy clinics. Drug Alcohol Depend (2004) 1.42
Implementing and evaluating a regional strategy to improve testing rates in VA patients at risk for HIV, utilizing the QUERI process as a guiding framework: QUERI Series. Implement Sci (2008) 1.27
Health care information technology in rural America: electronic medical record adoption status in meeting the national agenda. J Rural Health (2008) 1.24
Information technology in PBRNs: the Indiana University Medical Group Research Network (IUMG ResNet) experience. J Am Board Fam Med (2007) 1.24
Care coordination to increase referrals to smoking cessation telephone counseling: a demonstration project. Am J Manag Care (2008) 1.16
Information technology to support improved care for chronic illness. J Gen Intern Med (2007) 1.14
Use of electronic medical record data for quality improvement in schizophrenia treatment. J Am Med Inform Assoc (2004) 1.13
An HIV collaborative in the VHA: do advanced HIT and one-day sessions change the collaborative experience? Jt Comm J Qual Patient Saf (2006) 1.11
A network-based system to improve care for schizophrenia: the Medical Informatics Network Tool (MINT). J Am Med Inform Assoc (2004) 1.04
The role of health information technology in the translation of research into practice: an Oklahoma Physicians Resource/Research Network (OKPRN) study. J Am Board Fam Med (2007) 1.03
Design and implementation of the telemedicine-enhanced antidepressant management study. Gen Hosp Psychiatry (2005) 1.00
Moving implementation science forward. J Gen Intern Med (2006) 0.82
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet (2005) 29.45
Grading quality of evidence and strength of recommendations. BMJ (2004) 26.08
Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA (2003) 6.24
Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J Clin Oncol (2004) 5.12
GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). J Clin Epidemiol (2011) 5.10
Overview of the VA Quality Enhancement Research Initiative (QUERI) and QUERI theme articles: QUERI Series. Implement Sci (2008) 3.64
GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol (2010) 3.60
GRADE guidelines: 5. Rating the quality of evidence--publication bias. J Clin Epidemiol (2011) 3.44
GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol (2011) 3.30
Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin Cancer Res (2005) 3.30
Genetic test evaluation: information needs of clinicians, policy makers, and the public. Am J Epidemiol (2002) 3.23
Genes associated with breast cancer metastatic to bone. J Clin Oncol (2006) 3.21
Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays. Am J Pathol (2004) 3.04
AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions--agency for healthcare research and quality and the effective health-care program. J Clin Epidemiol (2010) 2.63
Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer. J Clin Oncol (2006) 2.48
Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension. Am J Respir Crit Care Med (2009) 2.40
The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med (2003) 2.31
ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension. Cardiovasc Res (2011) 2.03
Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy. Hypertension (2008) 2.00
Brain microglial cytokines in neurogenic hypertension. Hypertension (2010) 1.97
GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. J Clin Epidemiol (2012) 1.90
Making evidence from research more relevant, useful, and actionable in policy, program planning, and practice slips "twixt cup and lip". Am J Prev Med (2009) 1.78
Employer coverage of clinical preventive services in the United States. Am J Health Promot (2006) 1.77
Role of proinflammatory cytokines and redox homeostasis in exercise-induced delayed progression of hypertension in spontaneously hypertensive rats. Hypertension (2009) 1.74
Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models. Am J Respir Crit Care Med (2013) 1.71
Brain nuclear factor-kappa B activation contributes to neurohumoral excitation in angiotensin II-induced hypertension. Cardiovasc Res (2009) 1.70
The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med (2010) 1.64
AHRQ series paper 4: assessing harms when comparing medical interventions: AHRQ and the effective health-care program. J Clin Epidemiol (2008) 1.57
N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. in vitro characterization and pharmacokinetic properties. J Pharmacol Exp Ther (2003) 1.56
Gene transfer of extracellular superoxide dismutase improves endothelial function in rats with heart failure. Am J Physiol Heart Circ Physiol (2005) 1.55
Advancing evidence-based care for diabetes: lessons from the Veterans Health Administration. Health Aff (Millwood) (2007) 1.53
Evaluation of lower body positive pressure supported treadmill training for children with cerebral palsy. Pediatr Phys Ther (2011) 1.46
Cross-talk between cytokines and renin-angiotensin in hypothalamic paraventricular nucleus in heart failure: role of nuclear factor-kappaB. Cardiovasc Res (2008) 1.44
TNF-alpha-induced mitochondrial oxidative stress and cardiac dysfunction: restoration by superoxide dismutase mimetic Tempol. Am J Physiol Heart Circ Physiol (2007) 1.39
TNF-alpha blockade decreases oxidative stress in the paraventricular nucleus and attenuates sympathoexcitation in heart failure rats. Am J Physiol Heart Circ Physiol (2007) 1.37
Chronic NF-{kappa}B blockade reduces cytosolic and mitochondrial oxidative stress and attenuates renal injury and hypertension in SHR. Am J Physiol Renal Physiol (2008) 1.37
NF-kappaB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes. Cardiovasc Res (2009) 1.35
HDAC inhibition attenuates inflammatory, hypertrophic, and hypertensive responses in spontaneously hypertensive rats. Hypertension (2010) 1.35
Angiotensin II-induced hypertension is modulated by nuclear factor-κBin the paraventricular nucleus. Hypertension (2011) 1.33
Prevention of pulmonary hypertension by Angiotensin-converting enzyme 2 gene transfer. Hypertension (2009) 1.32
Microarray analysis reveals genetic pathways modulated by tipifarnib in acute myeloid leukemia. BMC Cancer (2004) 1.31
Heart failure and the brain: new perspectives. Am J Physiol Regul Integr Comp Physiol (2003) 1.30
Cardiovascular and renal sympathetic activation by blood-borne TNF-alpha in rat: the role of central prostaglandins. Am J Physiol Regul Integr Comp Physiol (2003) 1.30
Plasma membrane localization signals in the light chain of botulinum neurotoxin. Proc Natl Acad Sci U S A (2004) 1.29
Cytokine blockade attenuates sympathoexcitation in heart failure: cross-talk between nNOS, AT-1R and cytokines in the hypothalamic paraventricular nucleus. Eur J Heart Fail (2008) 1.28
Developing and sustaining quality improvement partnerships in the VA: the Colorectal Cancer Care Collaborative. J Gen Intern Med (2010) 1.25
Chronic exercise modulates RAS components and improves balance between pro- and anti-inflammatory cytokines in the brain of SHR. Basic Res Cardiol (2011) 1.24
The renin-angiotensin-aldosterone system excites hypothalamic paraventricular nucleus neurons in heart failure. Am J Physiol Heart Circ Physiol (2002) 1.23
Brain tumour necrosis factor-alpha modulates neurotransmitters in hypothalamic paraventricular nucleus in heart failure. Cardiovasc Res (2009) 1.21
Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer. J Mol Diagn (2008) 1.17
Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiol Behav (2005) 1.16
Inhibition of TNF in the brain reverses alterations in RAS components and attenuates angiotensin II-induced hypertension. PLoS One (2013) 1.15
AHRQ series paper 1: comparing medical interventions: AHRQ and the effective health-care program. J Clin Epidemiol (2008) 1.15
The Nlrp3 inflammasome promotes age-related thymic demise and immunosenescence. Cell Rep (2012) 1.14
Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injury. Neurochem Int (2007) 1.12
TNF-induced mitochondrial damage: a link between mitochondrial complex I activity and left ventricular dysfunction. Free Radic Biol Med (2008) 1.10
Updates on the antinociceptive mechanism hypothesis of botulinum toxin A. Parkinsonism Relat Disord (2011) 1.09
Novel chimeras of botulinum neurotoxins A and E unveil contributions from the binding, translocation, and protease domains to their functional characteristics. J Biol Chem (2008) 1.08
A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin. J Mol Diagn (2006) 1.08
Left behind: the legacy of hurricane Katrina. BMJ (2005) 1.08
Tumor necrosis factor-alpha induces renal vasoconstriction as well as natriuresis in mice. Am J Physiol Renal Physiol (2008) 1.08
Central adiposity, systemic inflammation, and the metabolic syndrome. Curr Hypertens Rep (2010) 1.05
Challenges in using nonrandomized studies in systematic reviews of treatment interventions. Ann Intern Med (2005) 1.05
Inflammation and oxidative stress are elevated in the brain, blood, and adrenal glands during the progression of post-traumatic stress disorder in a predator exposure animal model. PLoS One (2013) 1.05
Central TNF inhibition results in attenuated neurohumoral excitation in heart failure: a role for superoxide and nitric oxide. Basic Res Cardiol (2011) 1.02
Diet-induced renal changes in Zucker rats are ameliorated by the superoxide dismutase mimetic TEMPOL. Obesity (Silver Spring) (2009) 1.00
Observational studies in systematic [corrected] reviews of comparative effectiveness: AHRQ and the Effective Health Care Program. J Clin Epidemiol (2011) 0.99
Aging is associated with hypoxia and oxidative stress in adipose tissue: implications for adipose function. Am J Physiol Endocrinol Metab (2011) 0.97
A blueberry-enriched diet attenuates nephropathy in a rat model of hypertension via reduction in oxidative stress. PLoS One (2011) 0.97
(Pro)renin receptor mediates both angiotensin II-dependent and -independent oxidative stress in neuronal cells. PLoS One (2013) 0.97
Identification of molecular predictors of response in a study of tipifarnib treatment in relapsed and refractory acute myelogenous leukemia. Clin Cancer Res (2007) 0.95
Chronic exercise preserves renal structure and hemodynamics in spontaneously hypertensive rats. Antioxid Redox Signal (2011) 0.94
Infection of cardiomyocytes and induction of left ventricle dysfunction by neurovirulent polytropic murine retrovirus. J Virol (2007) 0.93
Angiotensin II causes imbalance between pro- and anti-inflammatory cytokines by modulating GSK-3β in neuronal culture. Br J Pharmacol (2013) 0.92
Aryl hydrocarbon exposure induces expression of MMP-9 in human prostate cancer cell lines. Cancer Lett (2004) 0.92
Identification of fibroblast growth factor receptor 3 (FGFR3) as a protein receptor for botulinum neurotoxin serotype A (BoNT/A). PLoS Pathog (2013) 0.91
Involvement of tumor necrosis factor-alpha in natriuretic response to systemic infusion of nitric oxide synthase inhibitor in anesthetized mice. Am J Physiol Renal Physiol (2010) 0.91
Paraventricular nucleus corticotrophin releasing hormone contributes to sympathoexcitation via interaction with neurotransmitters in heart failure. Basic Res Cardiol (2011) 0.90
Gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB receptor (GABABR) binding sites are distinctive from one another: molecular evidence. Neuropharmacology (2004) 0.90
Obesity increases cerebrocortical reactive oxygen species and impairs brain function. Free Radic Biol Med (2012) 0.89
QUERI and implementation research: emerging from adolescence into adulthood: QUERI Series. Implement Sci (2009) 0.89
Symbolic analysis detects alterations of cardiac autonomic modulation in congestive heart failure rats. Auton Neurosci (2009) 0.89
NF-κB in the paraventricular nucleus modulates neurotransmitters and contributes to sympathoexcitation in heart failure. Basic Res Cardiol (2011) 0.88
Effects of pyrrolidine dithiocarbamate on high-fat diet-induced metabolic and renal alterations in rats. Life Sci (2009) 0.88
Dose-response study of mobilisation and tactile stimulation therapy for the upper extremity early after stroke: a phase I trial. Neurorehabil Neural Repair (2011) 0.88
Dynamically repairing and replacing neural networks: using hybrid computational and biological tools. IEEE Pulse (2012) 0.87
TNF-α in hypothalamic paraventricular nucleus contributes to sympathoexcitation in heart failure by modulating AT1 receptor and neurotransmitters. Tohoku J Exp Med (2010) 0.87
Autonomic cardiovascular modulation. IEEE Eng Med Biol Mag (2009) 0.87
Cytokine mediation of experimental heart failure-induced anhedonia. Am J Physiol Regul Integr Comp Physiol (2003) 0.86
Identification and characterization of optimal gene expression markers for detection of breast cancer metastasis. J Mol Diagn (2005) 0.85
Gene expression profiles and prognostic markers for primary breast cancer. Methods Mol Biol (2007) 0.85
Validation of a medical record-based delirium risk assessment. J Am Geriatr Soc (2011) 0.84
A major ozonation product of cholesterol, 3beta-hydroxy-5-oxo-5,6-secocholestan-6-al, induces apoptosis in H9c2 cardiomyoblasts. FEBS Lett (2005) 0.84
New disease: motivational deficiency disorder: study ignores economic benefits. BMJ (2006) 0.83
Effects of performance measure implementation on clinical manager and provider motivation. J Gen Intern Med (2014) 0.83
Vasoreactivity before and after handgrip training in chronic heart failure patients. Atherosclerosis (2012) 0.82
Tesaglitazar, a dual peroxisome proliferator-activated receptor agonist (PPAR alpha/gamma), improves metabolic abnormalities and reduces renal injury in obese Zucker rats. Nephron Exp Nephrol (2009) 0.82
Prostate cancer cells show elevated urokinase receptor in a mouse model of metastasis. Cancer Cell Int (2006) 0.82
Effect of the HMG-CoA reductase inhibitor rosuvastatin on early chronic kidney injury in obese zucker rats fed with an atherogenic diet. Am J Med Sci (2009) 0.82